MedCity News

SEPTEMBER 15, 2024

To realize true, sustainable savings in total cost of care, the healthcare system needs to reconsider the support — or lack of support — it provides throughout patients’ medication experiences and the snowball effect that creates on a lifetime of healthcare costs.

Medical 116

Medical Healthcare Healthcare Patients 116

Clarivate

DECEMBER 14, 2021

As the COVID-19 pandemic continues to evolve, we are seeing substantial shifts in the way patients access healthcare and how providers deliver care. 2021 study had researched prescription drug topics online in the past year. More patients are using both pharma and third-party online info sources.

Pharma 52

Pharma Healthcare Healthcare Physicians 52

pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance.

Marketing 105

Marketing Sales Medical Patients 105

MedCity News

JANUARY 25, 2023

As healthcare organizations comply with the federal EPCS mandate, artificial intelligence and digital identity technologies should be utilized to detect, reduce, and remediate drug diversion.

Healthcare 116

Healthcare Healthcare Electronics Prescription 116

MedCity News

JUNE 16, 2023

The evolution to the new normal Given the evolving climate, Rock Health provided the apt advice as: “rather than aiming to ‘disrupt’ the entire healthcare system, focus is best placed on applying practiced skill sets to top healthcare and research problems.”

Pharma 123

Pharma Food and Drug Administration Recruitment Patients 123

Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Patients 52

Clarivate

FEBRUARY 28, 2023

Using real world data to analyze LHON dynamics To better understand the dynamics of LHON, including disease prevalence and drug usage in the United States, we analyzed real world data from electronic health records (EHR), claims and pharmacy data from healthcare institutions and providers. The Clarivate U.S.

Prescription 98

Prescription Patients Pharmacology Healthcare 98

PM360

SEPTEMBER 15, 2022

But battling information asymmetry is one of the best ways to address the ongoing inequities in our healthcare system. But to shift the industry’s approach to healthcare, all stakeholders must move the efforts, attention, and education necessary to find a common ground and ensure that the patients’ interests are always driving development.

Patients 98

Patients Healthcare Healthcare Marketing 98

pharmaphorum

JULY 27, 2022

Demerging Haleon has allowed GSK to focus on higher-margin prescription medicines and vaccines, as well as provide cash for investment in its biopharma pipeline. GSK’s HIV business, run through joint venture company ViiV Healthcare, also had a good quarter with sales up 14% to £1.4 Total revenues came in at £6.9

Sales 52

Sales Biopharma Prescription Medicine 52

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. In both cases, a shift in formulary placement could lower prescription volumes and reduce member utilization. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Veeva

AUGUST 15, 2021

Veeva OpenData has one of the most accurate customer reference data sets available in the market and provides access to a wide profile of healthcare professionals and healthcare organisations in Singapore. Veeva OpenData provides trusted customer reference data to help pharmaceutical companies better engage with their customers.

Sales 52

Sales Healthcare Healthcare Healthcare Provider 52

Clarivate

JULY 5, 2023

biologics market and reduce prescription drug costs. By end of year, as many as ten adalimumab biosimilars could be on the U.S. The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn.

Marketing 97

Marketing Physicians Manufacturing Competition 97

Pharmaceutical Technology

SEPTEMBER 8, 2022

The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. Prescription refill and renewal. Enrolment in patient assistance programmes and financial assistance. Patient monitoring for safety and efficacy.

Specialization 45

Specialization Leads Pharma Side effects 45

Pharmaceutical Technology

NOVEMBER 4, 2022

For example, digital twins of pharmaceutical supply chains can predict bottlenecks and give suggestions for how to respond using prescriptive AI. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

PM360

JULY 21, 2022

Though 80% of healthcare providers (HCPs) identified as “rep-accessible” in 2008 (that is, willing to meet with over 70% of the sales reps who try to approach them), that number had decreased to 44% in 2017. Fierce Healthcare. No biopharma or device advertisements appear during the prescribing workflow. References: 1.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. Nonetheless, Cailiff expressed optimism about US innovation and adaptability in the face of these changes.

FDA 52

FDA Prescription Medicine Biopharma 52

Clarivate

MAY 13, 2024

Many insurers use similar networks for Medicaid and exchange plans, so shifting to an exchange plan is less likely to cause a lapse in coverage or abandonment of prescription drugs or maintenance medications that control chronic conditions. Pillo, Senior Healthcare Research and Data Analyst. The post The U.S.

Insurance 52

Insurance Marketing Healthcare Healthcare 52

Eversana Intouch

FEBRUARY 23, 2023

Biopharma valuations are down, especially for public and earlier-stage companies. Healthcare delivery was unable to recover after the peak of the pandemic, and is still limping. Shifts in government healthcare policy and funding. Implications of economic volatility abound: Patients: Market access gaps. Formulary changes.

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Biopharma valuations are down, especially for public and earlier-stage companies. Healthcare delivery was unable to recover after the peak of the pandemic, and is still limping. Shifts in government healthcare policy and funding. Implications of economic volatility abound: Patients: Market access gaps. Formulary changes.

Marketing 52

Marketing Pharma Patients Insurance 52

Clarivate

OCTOBER 30, 2022

One exception is Pear Therapeutics, which has not only secured FDA clearance but also required a prescription for its reSET-O and Somryst apps. If Congress passes the Access to Prescription Digital Therapeutics Act, the market would be reinvigorated with the establishment of a payment methodology for Medicare reimbursement.

Insurance 52

Insurance FDA Marketing Prescription 52

Clarivate

DECEMBER 19, 2022

Insurers that incentivize using Walmart facilities in Medicare Advantage and prescription drug plans (PDPs) have seen success; Humana has a long-running standalone Part D plan with Walmart pharmacies as preferred network locations. To learn more about how Clarivate helps life science companies navigate the fast-changing U.S.

Competition 52

Competition Retail Insurance Marketing 52

Clarivate

MAY 11, 2023

Mainland China has streamlined regulatory protocols for testing and approving prescription drugs in recent years, making dozens of urgently needed treatments, from domestic and international manufacturers alike, available to patients in the process.

Marketing 52

Marketing Patients Management Insurance 52

Clarivate

NOVEMBER 23, 2021

Recently, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate spoke with Oriol Serra (at the time of recording Mr. Oriol Serra was Head of Site Intelligence & Site Selection at Pfizer) and Simon Andrews, Vice President of RWD Engagements and Innovations at Clarivate, on the topic.

Patients 52

Patients Recruitment Management Healthcare 52

Clarivate

MARCH 17, 2022

A section of the guidance, FDA Regulations That Govern Research in Pregnant Women , identifies several conditions that must be met in trials supported or conducted by HHS.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. Their authenticity and credibility is their superpower—don’t diminish that by being overly prescriptive. A tangible human goes a long way to making everybody more comfortable.

Patients 59

Patients Pharma Education Media 59

PM360

AUGUST 7, 2024

Whether you’re a social media manager aiming to enhance engagement, a medical affairs professional measuring the impact of healthcare initiatives, or a marketer refining campaign effectiveness, it is important to understand how to create the best possible outcome for your campaigns and programs.

Media 52

Media Education Physicians Marketing 52

Clarivate

AUGUST 8, 2023

The biopharma industry is sweating the long-term implications and warning that it could mean less lifesaving drugs make it to patients going forward. The law was top-of-mind at this summer’s ASCO and BIO meetings, tentpole events in the biopharma conference calendar. The vise on revenues also makes differentiation essential. “The

Biopharma 52

Biopharma Pharma Prescription Manufacturing 52

Clarivate

AUGUST 20, 2024

Moreover, the initial set of negotiated prices represents the first step of a process that eventually will reshape the pricing and reimbursement landscape for prescription drugs under Medicare as CMS gradually replaces private payers as the chief negotiating partner for some of the drug industry’s largest-selling treatments.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

World of DTC Marketing

JUNE 7, 2021

Retail price increases for widely used brand name prescription drugs consistently exceeded the rate of general inflation between 2006 and 2020. In 2020, retail prices for 260 brand-name prescription drugs widely used by older adults increased by an average of 2.9 In contrast, the general inflation rate was 1.3

Pharma 187

Pharma Retail Prescription Competition 187

Clarivate

OCTOBER 17, 2024

Healthcare delivery has not been the hottest topic on the campaign trail this election season, despite sharp policy differences between the candidates and parties. In public speeches, she has suggested possibly expanding the program beyond Medicare, presumably to the commercial insurance market (covering 47% of all lives in the U.S.).

Healthcare 52

Healthcare Healthcare Government Insurance 52